21 related articles for article (PubMed ID: 3152918)
1. Successful adoptive immunotherapy of minimal residual disease after chemoradiotherapy and transplantation of bone marrow purged of leukaemia with mafosfamide.
Skórski T; Kawalec M; Kawiak J
Cancer Immunol Immunother; 1990; 32(1):71-4. PubMed ID: 2289201
[TBL] [Abstract][Full Text] [Related]
2. Busulfan-melphalan in high-risk neuroblastoma: the 30-year experience of a single institution.
Proust-Houdemont S; Pasqualini C; Blanchard P; Dufour C; Benhamou E; Goma G; Semeraro M; Raquin MA; Hartmann O; Valteau-Couanet D
Bone Marrow Transplant; 2016 Aug; 51(8):1076-81. PubMed ID: 27042850
[TBL] [Abstract][Full Text] [Related]
3. Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas.
Peinemann F; Smith LA; Bartel C
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD008216. PubMed ID: 23925699
[TBL] [Abstract][Full Text] [Related]
4. Potential therapeutic role of cisplatinum in autologous bone marrow transplantation: in vitro eradication of neuroblastoma cells from bone marrow.
Bettan-Renaud L; de Vathaire F; Bénard J; Morardet N; Pauzie N; Bayet S; Hartmann O; Parmentier C
Br J Cancer; 1989 Oct; 60(4):529-32. PubMed ID: 2803923
[TBL] [Abstract][Full Text] [Related]
5. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow.
Mumcuoglu M; Naparstek E; Slavin S
Bone Marrow Transplant; 1990 Mar; 5(3):153-8. PubMed ID: 2184907
[TBL] [Abstract][Full Text] [Related]
6. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).
Slavin S; Mumcuoglu M; Landesberg-Weisz A; Kedar E
Bone Marrow Transplant; 1989 Sep; 4(5):459-64. PubMed ID: 2676042
[TBL] [Abstract][Full Text] [Related]
7. Hemopoietic reconstitution after repeated autologous transplantation with mafosfamide-purged marrow.
Beaujean F; Hartmann O; Benhamou E; Lemerle J; Duedari N
Bone Marrow Transplant; 1989 Sep; 4(5):537-41. PubMed ID: 2790332
[TBL] [Abstract][Full Text] [Related]
8. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
Rowley SD; Piantadosi S; Marcellus DC; Jones RJ; Davidson NE; Davis JM; Kennedy J; Wiley JM; Wingard JR; Yeager AM
Bone Marrow Transplant; 1991 Mar; 7(3):183-91. PubMed ID: 2059755
[TBL] [Abstract][Full Text] [Related]
9. Normal hematopoietic reconstitution following ASTA-Z 7557-purged grafts in the absence of in vitro CFU-GM colony growth.
Nagler A; Mumcuoglu M; Naparstek E; Or R; Gan S; Slavin S
Leuk Res; 1993 Jan; 17(1):61-7. PubMed ID: 8429681
[TBL] [Abstract][Full Text] [Related]
10. Incubation of autologous bone marrow graft with ASTA Z 7557: comparative studies of hematological reconstitution after purged or nonpurged bone marrow transplantation.
Beaujean F; Hartmann O; Pico J; Parmentier C; Hayat M; Lemerle J; Duédari N
Pediatr Hematol Oncol; 1987; 4(2):105-15. PubMed ID: 3152918
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow purging with mafosfamide--a critical survey.
Sindermann H; Peukert M; Hilgard P
Blut; 1989 Nov; 59(5):432-41. PubMed ID: 2684298
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]